Investments
3Portfolio Exits
1
Want to inform investors similar to Taparia Family about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Taparia Family News
Nov 8, 2022
PTI | Mumbai | Updated: 07-11-2022 21:24 IST | Created: 07-11-2022 21:24 IST Country: SHARE Nasdaq-listed Viatris on Monday announced the acquisition of Famy Life Sciences' ophthalmology business for Rs 2,500 crore. The city-based Taparia family, promoters of Famy , will retain the non-ophthalmic business consisting of oncology and other therapeutic areas, as per an official statement. This is the second big exit for the family after the Rs 5,000-crore sale of women's healthcare business Famy Care in 2015, as per the statement. The Taparia family was in news in 2016 for buying a 11,000-square feet duplex apartment in the central business district of Bandra Kurla Complex for Rs 60 crore. ''Viatris has been an excellent partner and this transaction creates a strong demonstration of value creation for an Indian company in the global innovation life sciences space,'' Famy Life Sciences' promoters Sanjeev and Ashutosh Taparia said. The company's directors Nidhi Agarwal and Anjali Biyani said they continue to see tremendous opportunities in the healthcare space which they will continue to pursue. Viatris is taking over a business consisting of a strong ophthalmic portfolio of phase 3 clinical assets in diseases such as dry eye, presbyopia and blepharitis, the statement said. There are unmet or under-served needs that can provide relief to large patient populations, it said, adding that 18 million people in the US alone get diagnosed with dry eye annually. (This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.) READ MORE ON:
Taparia Family Investments
3 Investments
Taparia Family has made 3 investments. Their latest investment was in dezerv as part of their Seed VC on September 9, 2021.
Taparia Family Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
9/2/2021 | Seed VC | dezerv | $7M | Yes | Aashish Sommaiyaa, Akash Saxena, Asish Mohapatra, Blume Ventures, CJ Shah, Elevation Capital, K Rangarajan, Kunal Shah, Matrix Partners India, Neeraj Goenka, Nitin Gupta, Ramakant Sharma, Revant Bhate, RK Kedia, Ruchi Kalra, Sanjeev Barnwal, Shashvat Nakrani, Suhail Sameer, Taparia Family, Varun Dua, Vidit Aatrey, and Whiteboard Capital | 9 |
5/24/2018 | Angel | |||||
4/2/2018 | Series A |
Date | 9/2/2021 | 5/24/2018 | 4/2/2018 |
|---|---|---|---|
Round | Seed VC | Angel | Series A |
Company | dezerv | ||
Amount | $7M | ||
New? | Yes | ||
Co-Investors | Aashish Sommaiyaa, Akash Saxena, Asish Mohapatra, Blume Ventures, CJ Shah, Elevation Capital, K Rangarajan, Kunal Shah, Matrix Partners India, Neeraj Goenka, Nitin Gupta, Ramakant Sharma, Revant Bhate, RK Kedia, Ruchi Kalra, Sanjeev Barnwal, Shashvat Nakrani, Suhail Sameer, Taparia Family, Varun Dua, Vidit Aatrey, and Whiteboard Capital | ||
Sources | 9 |
Taparia Family Portfolio Exits
1 Portfolio Exit
Taparia Family has 1 portfolio exit. Their latest portfolio exit was Fitternity on February 09, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
2/9/2021 | Acquired | 7 |
Date | 2/9/2021 |
|---|---|
Exit | Acquired |
Companies | |
Valuation | |
Acquirer | |
Sources | 7 |
Taparia Family Acquisitions
1 Acquisition
Taparia Family acquired 1 company. Their latest acquisition was Guardian Lifecare on August 26, 2016.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
8/26/2016 | Corporate Majority | 1 |
Date | 8/26/2016 |
|---|---|
Investment Stage | |
Companies | |
Valuation | |
Total Funding | |
Note | Corporate Majority |
Sources | 1 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.